API reference

Carisoprodol

CAS number
78-44-4
Molecular formula
C12H24N2O4
Molecular weight
260.33 g/mol
Carisoprodol — 2D structure
2D structure (PubChem)

About this molecule

Originally approved by the FDA in 1959, carisoprodol is a centrally acting muscle relaxant used in painful musculoskeletal conditions in conjunction with physical therapy and other medications. This drug is available by itself in an oral tablet or combined with aspirin, or in a fixed-dose combination with both aspirin and codeine. In January 2012, this drug was classified as a Schedule IV substance under the controlled substances act in several US states due to alarming rates of abuse despite having a low potential for abuse in addition to a low risk of dependence.

Source: DrugBank, via PubChem.

Identifiers

IUPAC name
[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate
InChIKey
OFZCIYFFPZCNJE-UHFFFAOYSA-N
SMILES
CCCC(C)(COC(=O)N)COC(=O)NC(C)C
PubChem CID
2576

Also known as

carisoprodol · Isomeprobamate · Carisoprodate · SOMA · Carisoprodatum · Carisoma · Isobamate · Isoprothane

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com